Turkey - Re-Imbursed Pharmaceutical Market
Since 2014, Turkey Re-Imbursed Pharmaceutical Market was up 3.3points year on year. With 36.2 Percent of Generics in Value in 2019, the country was ranked number 3 comparing other countries in Re-Imbursed Pharmaceutical Market. Turkey is overtaken by United Kingdom, which was ranked number 2 with 38.5 Percent of Generics in Value and is followed by New Zealand at 33.1 Percent of Generics in Value. Austria ranked the highest with 52.2 Percent of Generics in Value in 2019, that is a growth of 2.8points compared to 2018. Denmark recorded the best 5 years average growth at +6.9points per year, while Slovakia was the worst growing country at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 36.20 |
| 2018 | 37.60 |
| 2017 | 32.30 |
| 2016 | 32.20 |
| 2015 | 30.80 |
Download all data from 2008 to 2019
How does Turkey rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data |
| 3 |
#3
Turkey
|
36.20 % | 2019 | -3.7 % | +3.3 % | View data |
| 4 |
#4
New Zealand
|
33.10 % | 2019 | +1.2 % | +0.7 % | View data |
| 5 |
#5
Germany
|
32.90 % | 2019 | +1.5 % | -1.9 % | View data |